1,528
Views
106
CrossRef citations to date
0
Altmetric
Review

Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Sowmya Ramachandran, Priyanka Prakash, Noratiqah Mohtar, K. Sudesh Kumar & Thaigarajan Parumasivam. (2023) Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs. Pharmaceutical Development and Technology 0:0, pages 1-14.
Read now
Ileana García-Silva, Dania O Govea-Alonso & Sergio Rosales-Mendoza. (2023) Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity. Expert Opinion on Biological Therapy 23:2, pages 207-222.
Read now
Pengfei Yue, Weicheng Zhou, Guiting Huang, Fangfang Lei, Yingchong Chen, Zhilin Ma, Liru Chen & Ming Yang. (2022) Nanocrystals based pulmonary inhalation delivery system: advance and challenge. Drug Delivery 29:1, pages 637-651.
Read now
Wenli Zhang, Enshi Hu, Yajie Wang, Si Miao, Yanyan Liu, Yumin Hu$suffix/text()$suffix/text(), Ji Liu, Bohui Xu, Daquan Chen & Yan Shen. (2021) Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment. International Journal of Nanomedicine 16, pages 6141-6156.
Read now
Leonor de Braganca, G. John Ferguson, Jose Luis Santos & Jeremy P. Derrick. (2021) Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung. Journal of Immunotoxicology 18:1, pages 61-73.
Read now
Muhammad Usman Munir, Arsalan Ahmed, Muhammad Usman & Sajal Salman. (2020) Recent Advances in Nanotechnology-Aided Materials in Combating Microbial Resistance and Functioning as Antibiotics Substitutes. International Journal of Nanomedicine 15, pages 7329-7358.
Read now
Fakhar ud Din, Waqar Aman, Izhar Ullah, Omer Salman Qureshi, Omer Mustapha, Shumaila Shafique & Alam Zeb. (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International Journal of Nanomedicine 12, pages 7291-7309.
Read now
Abdelwahab Omri. (2015) Pulmonary drug and vaccine delivery: therapeutic significance and major challenges. Expert Opinion on Drug Delivery 12:6, pages 853-855.
Read now

Articles from other publishers (98)

Liaoran Niu, Qi Wang, Fan Feng, Wanli Yang, Zhenyu Xie, Gaozan Zheng, Wei Zhou, Lili Duan, Kunli Du, Yiding Li, Ye Tian, Junfeng Chen, Qibin Xie, Aqiang Fan, Hanjun Dan, Jinqiang Liu, Daiming Fan, Liu Hong, Jian Zhang & Jianyong Zheng. (2024) Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870:2, pages 166917.
Crossref
Mumuni Sumaila, Pradeep Kumar, Philemon Ubanako, Samson A. Adeyemi & Yahya E. Choonara. (2023) Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery. Current Drug Delivery 20:10, pages 1487-1503.
Crossref
Bushra Tousian & Ali Reza Khosravi. (2023) Chitosan-based pulmonary particulate systems for anticancer and antiviral drug carriers: A promising delivery for COVID-19 vaccines. Results in Chemistry 6, pages 101146.
Crossref
Mingze Xu, Yuming Qi, Gaoshuo Liu, Yuanqing Song, Xingya Jiang & Bujie Du. (2023) Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance . ACS Nano 17:21, pages 20825-20849.
Crossref
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, Keshav Raj Paudel, Parteek Prasher, Vyoma K Patel, Leander Corrie, Dinesh Kumar Chellappan, Gaurav Gupta, Sachin Kumar Singh, Vandana Patravale, John Disouza & Kamal Dua. (2023) Inhalation drug delivery in combating pulmonary infections: Advances and challenges. Journal of Drug Delivery Science and Technology 89, pages 105022.
Crossref
Zhaokui Jin, Qi Gao, Keke Wu, Jiang Ouyang, Weisheng Guo & Xing-Jie Liang. (2023) Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Advanced Drug Delivery Reviews 202, pages 115111.
Crossref
Qinqin Fei, Emily M. Shalosky, Ryelie Barnes, Vasudha C. Shukla, Siying Xu, Megan N. Ballinger, Laszlo Farkas, Robert J. Lee, Samir N. Ghadiali & Joshua A. Englert. (2023) Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome. ACS Nano.
Crossref
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, Kartik Bomb & Catherine A. Fromen. (2023) Aerosol pulmonary immune engineering. Advanced Drug Delivery Reviews 199, pages 114831.
Crossref
Emerson L. Grey, Jazalle McClendon, Joshita Suresh, Scott Alper, William J. Janssen & Stephanie J. Bryant. (2023) Thiol-Michael Addition Microparticles: Their Synthesis, Characterization, and Uptake by Macrophages. ACS Biomaterials Science & Engineering 9:7, pages 4223-4240.
Crossref
Teerapol Srichana, Ekawat Thawithong, Titpawan Nakpheng & Pijush Kumar Paul. (2023) Flow cytometric analysis, confocal laser scanning microscopic, and holotomographic imaging demonstrate potentials of levofloxacin dry powder aerosols for TB treatment. Journal of Drug Delivery Science and Technology 84, pages 104464.
Crossref
Sandra Robla, Rubén Varela Calviño, Rita Ambrus & Noemi Csaba. (2023) A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery. European Journal of Pharmaceutical Sciences 185, pages 106442.
Crossref
Phumzile P. Skosana, Steward Mudenda, Patrick H. Demana & Bwalya A. Witika. (2023) Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections. ACS Omega 8:18, pages 15865-15882.
Crossref
Hitesh Chopra, Yugal Kishore Mohanta, Pradipta Ranjan Rauta, Ramzan Ahmed, Saurov Mahanta, Piyush Kumar Mishra, Paramjot Panda, Ali A. Rabaan, Ahmad A. Alshehri, Basim Othman, Mohammed Abdulrahman Alshahrani, Ali S. Alqahtani, Baneen Ali AL Basha & Kuldeep Dhama. (2023) An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management. Pharmaceuticals 16:4, pages 581.
Crossref
Zicheng YuTingting WuXiaoyan LiuHongjun ChenChunxia RenLifei Zhu. (2023) Resveratrol-Loaded Dipalmitoylphosphatidylcholine Liposomal Large Porous Microparticle Inhalations for the Treatment of Bacterial Pneumonia Caused by Acinetobacter baumannii . Journal of Aerosol Medicine and Pulmonary Drug Delivery 36:1, pages 2-11.
Crossref
Katherine González, Gauri Gangapurwala, Julien Alex, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert & Axel A. Brakhage. (2022) Targeting of phagolysosomes containing conidia of the fungus Aspergillus fumigatus with polymeric particles. Applied Microbiology and Biotechnology 107:2-3, pages 819-834.
Crossref
Rishi Raj, Gunjan Nagpure, Kshitij RB Singh, Jay Singh & Ravindra Pratap Singh. 2023. Nanotechnology for Drug Delivery and Pharmaceuticals. Nanotechnology for Drug Delivery and Pharmaceuticals 29 42 .
Thomas Manning, Jenu Thomas-Richardson, Courtney Johnson, Krupesh Patel, Yatri Thaker, Govind Thomas-Richardson, Dennis Philips & Greg Wylie. 2023. Tuberculosis. Tuberculosis 305 320 .
Chetna Gupta, Aadya Jaipuria & Nikesh Gupta. (2022) Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments. Pharmaceutics 15:1, pages 139.
Crossref
Eleftherios Halevas, Barbara Mavroidi, Chrysoula Kokotidou, Alexandra Moschona, Marina Sagnou, Anna Mitraki, George Litsardakis & Maria Pelecanou. (2022) Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery. Journal of Drug Delivery Science and Technology 75, pages 103625.
Crossref
Priyanka Maurya, Ravi Saklani, Samipta Singh, Raquibun Nisha, Ravi Raj Pal, Nidhi Mishra, Priya Singh, Abhiram Kumar, Manish K. Chourasia & Shubhini A. Saraf. (2021) Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages. Drug Delivery and Translational Research 12:7, pages 1640-1658.
Crossref
Le Tri Vien, Nguyen Thi Nga, Phung Thi Kim Hue, Tran Hoang Bao Kha, Nguyen Hong Hoang, Pham Thi Hue, Pham Ngoc Thien, Chi-Ying F Huang, Phan Van Kiem & Do Thi Thao. (2022) A New Liposomal Formulation of Hydrogenated Anacardic Acid to Improve Activities Against Cancer Stem Cells. Natural Product Communications 17:6, pages 1934578X2211056.
Crossref
Francesca Garello, Yulia Svenskaya, Bogdan Parakhonskiy & Miriam Filippi. (2022) Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents. Pharmaceutics 14:6, pages 1132.
Crossref
Ahmed M. Abu-Dief, Mosa Alsehli, Abdullah Al-Enizi & Ayman Nafady. (2022) Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications. Current Drug Delivery 19:4, pages 436-450.
Crossref
Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, Murtaza M Tambuwala, Parteek Prasher, Keshav R Paudel, Gang Liu, Shakti D Shukla, Philip M Hansbro, Dinesh Kumar Chellappan, Kamal Dua & Saurabh Satija. (2022) Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future Medicinal Chemistry 14:4, pages 271-288.
Crossref
Pallavi Raj Sharma, Ameya Atul Dravid, Yeswanth Chakravarthy Kalapala, Vishal K. Gupta, Sharumathi Jeyasankar, Avijit Goswami & Rachit Agarwal. (2022) Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages. Biomaterials Advances 133, pages 112612.
Crossref
Sara A. Valente, Lisete M. Silva, Guido R. Lopes, Bruno Sarmento, Manuel A. Coimbra & Cláudia P. Passos. (2022) Polysaccharide-based formulations as potential carriers for pulmonary delivery – A review of their properties and fates. Carbohydrate Polymers 277, pages 118784.
Crossref
Silvana Alfei, Andrea Spallarossa, Matteo Lusardi & Guendalina Zuccari. (2022) Successful Dendrimer and Liposome-Based Strategies to Solubilize an Antiproliferative Pyrazole Otherwise Not Clinically Applicable. Nanomaterials 12:2, pages 233.
Crossref
Vishal Puri, Kabi Raj Chaudhary, Arti Singh & Charan Singh. (2022) Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: In vitro lung deposition and efficacy studies. Current Research in Pharmacology and Drug Discovery 3, pages 100084.
Crossref
Anil K. Philip, Betty Annie Samuel, Kamran Ashraf & Md. Faiyazuddin. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 609 621 .
Mangesh Pradeep Kulkarni, Poluri Sesha Sai Kiran & Rajesh Kumar. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 471 492 .
Pradeep Kumar. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 359 373 .
Chandrakantsing V. Pardeshi, Sagar R. Pardeshi & Jitendra B. Naik. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 219 258 .
Arun K. Kotha, Rama Kashikar, Paras Famta, Saurabh Shah, Saurabh Srivastava & Mahavir Bhupal Chougule. 2022. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications. Nanomaterials for Cancer Detection Using Imaging Techniques and Their Clinical Applications 225 259 .
Liya Sun, Yuan Liu, Xiali Liu, Rui Wang, Jiameng Gong, Aabida Saferali, Wei Gao, Aying Ma, Huiqiang Ma, Stuart E. Turvey, Shan‐Yu Fung & Hong Yang. (2021) Nano‐Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury. Advanced Science 9:3.
Crossref
Seta Noventa, Matthew S. P. Boyles, Andreas Seifert, Simone Belluco, Aracaeli Sánchez Jiménez, Helinor J. Johnston, Lang Tran, Teresa F. Fernandes, Lapo Mughini-Gras, Massimiliano Orsini, Fabiana Corami, Kepa Castro, Franco Mutinelli, Massimo Boldrin, Victor Puntes, Mahshid Sotoudeh, Giulia Mascarello, Barbara Tiozzo, Polly McLean, Francesca Ronchi, Andy M. Booth, Albert A. Koelmans & Carmen Losasso. (2021) Paradigms to assess the human health risks of nano- and microplastics. Microplastics and Nanoplastics 1:1.
Crossref
Alba García-Fernández, Félix Sancenón & Ramón Martínez-Máñez. (2021) Mesoporous silica nanoparticles for pulmonary drug delivery. Advanced Drug Delivery Reviews 177, pages 113953.
Crossref
Santhni Subramaniam, Paul Joyce, Nicky Thomas & Clive A. Prestidge. (2021) Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Advanced Drug Delivery Reviews 177, pages 113948.
Crossref
Tobias A. Bauer, Natalie K. Horvat, Oriana Marques, Sara Chocarro, Christina Mertens, Silvia Colucci, Sascha Schmitt, Luca M. Carrella, Svenja Morsbach, Kaloian Koynov, Federico Fenaroli, Peter Blümler, Michaela Jung, Rocio Sotillo, Matthias W. Hentze, Martina U. Muckenthaler & Matthias Barz. (2021) Core Cross‐Linked Polymeric Micelles for Specific Iron Delivery: Inducing Sterile Inflammation in Macrophages. Advanced Healthcare Materials 10:19.
Crossref
Ibrahim M. Abdulbaqi, Reem Abou Assi, Anan Yaghmur, Yusrida Darwis, Noratiqah Mohtar, Thaigarajan Parumasivam, Fadi G. Saqallah & Habibah A. Wahab. (2021) Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals 14:8, pages 725.
Crossref
Bret BernerTomoyuki Okuda & Hak‐Kim Chan. 2021. Drug Delivery Approaches. Drug Delivery Approaches 305 332 .
Omar A. Elkady, Layla M. Saleh, Mina Ibrahim Tadros & Hanan M. El-laithy. (2021) Nebulization of Risedronate Sodium Microspheres for Potential Attenuation of Pulmonary Emphysema: a Promising New Insight of Alveolar Macrophage Apoptosis. AAPS PharmSciTech 22:5.
Crossref
Pragya Prasanna, Shweta Rathee, Arun Upadhyay & Sulakshana Sulakshana. (2021) Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sciences 276, pages 119428.
Crossref
Muhammad Sohail, Wenna Guo, Zhiyong Li, Hui Xu, Feng Zhao, Daquan Chen & Fenghua Fu. (2021) Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade. Current Medicinal Chemistry 28:19, pages 3753-3772.
Crossref
Zicheng Deng, Gregory T. Kalin, Donglu Shi & Vladimir V. Kalinichenko. (2021) Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases. American Journal of Respiratory Cell and Molecular Biology 64:3, pages 292-307.
Crossref
Do Thi Thao, Le Nhat Minh, Tran Thi Minh Anh, Nguyen Thi Nga, Phung Thi Kim Hue & Phan Van Kiem. (2021) The Improved Anticancer Activities of Piperine Nanoliposome Conjugated CD133 Monoclonal Antibody Against NTERA-2 Cancer Stem Cells. Natural Product Communications 16:2, pages 1934578X2199818.
Crossref
Pamelia N. Lim, Maritza M. Cervantes, Linh K. Pham & Alissa C. Rothchild. (2021) Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Reviews in Molecular Medicine 23.
Crossref
Jia Liu, Yan Deng, Daan Fu, Ye Yuan, Qilin Li, Lin Shi, Guobin Wang, Zheng Wang & Lin Wang. (2021) Sericin microparticles enveloped with metal-organic networks as a pulmonary targeting delivery system for intra-tracheally treating metastatic lung cancer. Bioactive Materials 6:1, pages 273-284.
Crossref
Kapil Sharma. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy 281 306 .
Dhiren P. Shah. 2021. Nanocarriers: Drug Delivery System. Nanocarriers: Drug Delivery System 3 42 .
Jigar D. Vanza, Rashmin B. Patel & Mrunali R. Patel. (2020) Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 60, pages 102070.
Crossref
Eiji Saito, Stephen J. GurczynskiKevin R. KramerCarol A. Wilke, Stephen D. Miller, Bethany B. Moore & Lonnie D. Shea. (2020) Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease. Science Advances 6:42.
Crossref
Marika Pilou. (2020) Aerosol Particle Deposition in the Lungs: Effect of Breathing Patterns. Aerosol Particle Deposition in the Lungs: Effect of Breathing Patterns.
Renata Ribeiro de Castro, Valério Todaro, Luiz Claudio Rodrigues Pereira da Silva, Alice Simon, Flavia Almada do Carmo, Valeria Pereira de Sousa, Carlos Rangel Rodrigues, Bruno Sarmento, Anne Marie Healy & Lucio Mendes Cabral. (2020) Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis. Journal of Drug Delivery Science and Technology 58, pages 101805.
Crossref
Tomoyuki Okuda & Hirokazu Okamoto. (2020) Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions. Chemical and Pharmaceutical Bulletin 68:7, pages 589-602.
Crossref
Alicia Lacoma, Laura Usón, Gracia Mendoza, Victor Sebastián, Esther Garcia-Garcia, Beatriz Muriel-Moreno, Jose Domínguez, Manuel Arruebo & Cristina Prat. (2020) Novel intracellular antibiotic delivery system against Staphylococcus aureus : cloxacillin-loaded poly( d , l -lactide-co-glycolide) acid nanoparticles . Nanomedicine 15:12, pages 1189-1203.
Crossref
Eleonora Truzzi, Thais Leite Nascimento, Valentina Iannuccelli, Luca Costantino, Eliana Martins Lima, Eliana Leo, Cristina Siligardi, Magdalena Lassinantti Gualtieri & Eleonora Maretti. (2020) In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?. Nanomaterials 10:3, pages 568.
Crossref
Qiaoyu Liu, Jian Guan, Lu Qin, Xin Zhang & Shirui Mao. (2020) Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery. Drug Discovery Today 25:1, pages 150-159.
Crossref
Abdel Naser Dakkah, Yazan Bataineh, Bilal A Al Jaidi, Mohammad F. Bayan & Nabil A. Nimer. 2020. Integrative Nanomedicine for New Therapies. Integrative Nanomedicine for New Therapies 357 404 .
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Alaa S. Tulbah, Elvira Pisano, Emelie Landh, Santo Scalia, Paul M. Young, Daniela Traini & Hui Xin Ong. (2019) Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages. Journal of Pharmaceutical Sciences 108:12, pages 3890-3897.
Crossref
Duy-Khiet Ho, Brittany L.B. Nichols, Kevin J. Edgar, Xabier Murgia, Brigitta Loretz & Claus-Michael Lehr. (2019) Challenges and strategies in drug delivery systems for treatment of pulmonary infections. European Journal of Pharmaceutics and Biopharmaceutics 144, pages 110-124.
Crossref
Adam Bajgar, Ivan Saloň, Gabriela Krejčová, Tomáš Doležal, Marek Jindra & František Štěpánek. (2019) Yeast glucan particles enable intracellular protein delivery in Drosophila without compromising the immune system . Biomaterials Science 7:11, pages 4708-4719.
Crossref
Maretti, Rustichelli, Lassinantti Gualtieri, Costantino, Siligardi, Miselli, Buttini, Montecchi, Leo, Truzzi & Iannuccelli. (2019) The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. Pharmaceutics 11:10, pages 508.
Crossref
Natasa Gaspar, Giorgia Zambito, Clemens M.W.G. Löwik & Laura Mezzanotte. (2019) Active Nano-targeting of Macrophages. Current Pharmaceutical Design 25:17, pages 1951-1961.
Crossref
Tomasz Urbaniak & Witold Musiał. (2019) Influence of Solvent Evaporation Technique Parameters on Diameter of Submicron Lamivudine-Poly-ε-Caprolactone Conjugate Particles. Nanomaterials 9:9, pages 1240.
Crossref
Farideh Shiehzadeh, Farzin Hadizadeh, Amirhoushang Mohammadpour, Ehsan Aryan, Leila Gholami & Mohsen Tafaghodi. (2019) Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule. Journal of Drug Delivery Science and Technology 52, pages 957-967.
Crossref
Sharif Abdelghany, Thaigarajan Parumasivam, Angel Pang, Ben Roediger, Patricia Tang, Kristina Jahn, Warwick John Britton & Hak-Kim Chan. (2019) Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis. Journal of Drug Delivery Science and Technology 52, pages 642-651.
Crossref
Stephen N. Crooke, Jiri Schimer, Idris Raji, Bocheng Wu, Adegboyega K. Oyelere & M. G. Finn. (2019) Lung Tissue Delivery of Virus-Like Particles Mediated by Macrolide Antibiotics. Molecular Pharmaceutics 16:7, pages 2947-2955.
Crossref
Ankur Sharma, Kalpesh Vaghasiya, Eupa Ray, Pushpa Gupta, Amit Kumar Singh, Umesh Datta Gupta & Rahul Kumar Verma. (2019) Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis. International Journal of Pharmaceutics 558, pages 231-241.
Crossref
Eleonora Maretti, Luca Costantino, Francesca Buttini, Cecilia Rustichelli, Eliana Leo, Eleonora Truzzi & Valentina Iannuccelli. (2018) Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy. Drug Delivery and Translational Research 9:1, pages 298-310.
Crossref
Siyang Song, Wenshu Cong, Shurong Zhou, Yujie Shi, Wenbing Dai, Hua Zhang, Xueqing Wang, Bing He & Qiang Zhang. (2019) Small GTPases: Structure, biological function and its interaction with nanoparticles. Asian Journal of Pharmaceutical Sciences 14:1, pages 30-39.
Crossref
Prameswari Kasa, Batoul Farran & Ganji Seeta Rama Raju. 2019. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy 159 174 .
Xiaoling Gao, Lihua Guo, Jianqiang Li, Hnin Ei Thu & Zahid Hussain. (2018) Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition. Journal of Controlled Release 292, pages 29-57.
Crossref
Tejal Rawal, Snehal Patel & Shital Butani. (2018) Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline. European Journal of Pharmaceutical Sciences 124, pages 273-287.
Crossref
Mirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, Patrizia Perri & Chiara Brignole. (2018) Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer. International Journal of Molecular Sciences 19:7, pages 1953.
Crossref
Byungji Kim, Hong-Bo Pang, Jinyoung Kang, Ji-Ho Park, Erkki Ruoslahti & Michael J. Sailor. (2018) Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus. Nature Communications 9:1.
Crossref
Duy-Khiet Ho, Ana Costa, Chiara De Rossi, Cristiane de Souza Carvalho-Wodarz, Brigitta Loretz & Claus-Michael Lehr. (2018) Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake. Molecular Pharmaceutics 15:3, pages 1081-1096.
Crossref
Weiwei Gao, Yijie Chen, Yue Zhang, Qiangzhe Zhang & Liangfang Zhang. (2018) Nanoparticle-based local antimicrobial drug delivery. Advanced Drug Delivery Reviews 127, pages 46-57.
Crossref
Roberto Nisini, Noemi Poerio, Sabrina Mariotti, Federica De Santis & Maurizio Fraziano. (2018) The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Frontiers in Immunology 9.
Crossref
Amin A. El-Meligi. (2017) Application of nanomaterials in the field of nanomedicine. Application of nanomaterials in the field of nanomedicine.
Valikala Viswanath & Kannappan Santhakumar. (2017) Perspectives on dendritic architectures and their biological applications: From core to cell. Journal of Photochemistry and Photobiology B: Biology 173, pages 61-83.
Crossref
Susana Rodrigues, Ana D. Alves, Joana S. Cavaco, Jorge F. Pontes, Filipa Guerreiro, Ana M. Rosa da Costa, Francesca Buttini & Ana Grenha. (2017) Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles. International Journal of Pharmaceutics 529:1-2, pages 433-441.
Crossref
Eleonora Maretti, Luca Costantino, Cecilia Rustichelli, Eliana Leo, Maria Antonietta Croce, Francesca Buttini, Eleonora Truzzi & Valentina Iannuccelli. (2017) Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α- d -mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. International Journal of Pharmaceutics 528:1-2, pages 440-451.
Crossref
Tejal Rawal, Rajesh Parmar, Rajeev K. Tyagi & Shital Butani. (2017) Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis. Colloids and Surfaces B: Biointerfaces 154, pages 321-330.
Crossref
Dania Movia, Luisana Di Cristo, Roaa Alnemari, Joseph E. McCarthy, Hanane Moustaoui, Marc Lamy de la Chapelle, Jolanda Spadavecchia, Yuri Volkov & Adriele Prina-Mello. (2017) The curious case of how mimicking physiological complexity in in vitro models of the human respiratory system influences the inflammatory responses. A preliminary study focused on gold nanoparticles. Journal of Interdisciplinary Nanomedicine 2:2, pages 110-130.
Crossref
Lifei Zhu, Miao Li, Xiaoyan Liu & Yiguang Jin. (2017) Drug-Loaded PLGA Electrospraying Porous Microspheres for the Local Therapy of Primary Lung Cancer via Pulmonary Delivery. ACS Omega 2:5, pages 2273-2279.
Crossref
Bert Müller & Marcel Van de VoordeMarcel Van de Voorde & Pankaj Vadgama. 2017. Nanoscience and Nanotechnology for Human Health. Nanoscience and Nanotechnology for Human Health 9 20 .
Lifei Zhu, Miao Li, Xiaoyan Liu, Lina Du & Yiguang Jin. (2017) Inhalable oridonin-loaded poly(lactic- co -glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer. Acta Pharmaceutica Sinica B 7:1, pages 80-90.
Crossref
Young H. Lim, Kristin M. Tiemann, David A. Hunstad, Mahmoud Elsabahy & Karen L. Wooley. (2016) Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. WIREs Nanomedicine and Nanobiotechnology 8:6, pages 842-871.
Crossref
Simon Lee, Saul Kivimäe, Aaron Dolor & Francis C. Szoka. (2016) Macrophage-based cell therapies: The long and winding road. Journal of Controlled Release 240, pages 527-540.
Crossref
Cristina Prat & Alicia Lacoma. (2016) Bacteria in the respiratory tract—how to treat? Or do not treat?. International Journal of Infectious Diseases 51, pages 113-122.
Crossref
Kleanthis Fytianos, Barbara Drasler, Fabian Blank, Christophe von Garnier, Emilie Seydoux, Laura Rodriguez-Lorenzo, Alke Petri-Fink & Barbara Rothen-Rutishauser. (2016) Current in vitro approaches to assess nanoparticle interactions with lung cells . Nanomedicine 11:18, pages 2457-2469.
Crossref
Nobutoshi Ota, Yuri Owa, Takayuki Kawai & Yo Tanaka. (2016) Micro/nanoparticle separation via curved nano-gap device with enhanced size resolution. Journal of Chromatography A 1455, pages 172-177.
Crossref
Muhammad Sarfraz, Wenjun Shi, Yuan Gao, Sophie-Dorothee Clas, Wilson Roa, Nadia Bou-Chacra & Raimar Löbenberg. (2016) Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages. Therapeutic Delivery 7:4, pages 213-228.
Crossref
Carlotta Marianecci, Stefania Petralito, Federica Rinaldi, Patrizia N. Hanieh & Maria Carafa. (2016) Some recent advances on liposomal and niosomal vesicular carriers. Journal of Drug Delivery Science and Technology 32, pages 256-269.
Crossref
Megan N. Ballinger & John W. Christman. (2016) Pulmonary Macrophages: Overlooked and Underappreciated. American Journal of Respiratory Cell and Molecular Biology 54:1, pages 1-2.
Crossref
Albert Duschl. 2016. Immune Rebalancing. Immune Rebalancing 251 274 .
Wing-Hin Lee, Ching-Yee Loo, Daniela Traini & Paul M. Young. (2015) Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges. Asian Journal of Pharmaceutical Sciences 10:6, pages 481-489.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.